Evoke Pharma
Evoke Pharma (EVOK) is a specialty pharmaceutical company focused on the development and commercialization of drugs primarily for the treatment of gastrointestinal (GI) disorders. The company's flagship product is Gimoti, a nasal spray formulation of metoclopramide, designed to relieve symptoms of acute and recurrent diabetic gastroparesis in adult women. Evoke Pharma operates within the biopharmaceutical sector, with an emphasis on addressing unmet medical needs in the GI space.